1153 related articles for article (PubMed ID: 18585941)
1. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
Moeller JJ; Rahey SR; Sadler RM
Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
[TBL] [Abstract][Full Text] [Related]
5. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
6. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine in children with refractory epilepsy.
Celebi A; Yalnmzoğlu D; Turanli G; Topaloğlu H; Aysun S; Topçu M
Turk J Pediatr; 2008; 50(5):426-31. PubMed ID: 19102045
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
16. [Lamotrigine in refractory partial and general epilepsies].
Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine therapy of epilepsy with Angelman's syndrome.
Dion MH; Novotny EJ; Carmant L; Cossette P; Nguyen DK
Epilepsia; 2007 Mar; 48(3):593-6. PubMed ID: 17326790
[TBL] [Abstract][Full Text] [Related]
18. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological outcomes in newly diagnosed epilepsy.
Mohanraj R; Brodie MJ
Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
[TBL] [Abstract][Full Text] [Related]
20. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Schapel G; Chadwick D
Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
